Power of 10: Our impact in the East Midlands

Founded in 2021 by husband and wife team, Professors Stephen and Georgina Jackson, with Dr Barbara Morera at the University of Nottingham, Neupulse is pioneering a safe, non-drug treatment to help manage the symptoms of Tourette’s syndrome.

The wristband device stimulates the median nerve in the wrist to help control the tics or involuntary movements caused by Tourette’s syndrome. Clinical trials have shown the device can reduce tic frequency on average by 25% on initial use, with a further reduction in frequency after four weeks of use.

The funding will enable the company to finalise development of its device and carry out further trials as it seeks to gain regulatory approvals in the UK, Europe and the USA. It follows a £2.5 million investment earlier this year from a consortium including Eos Advisory and US-based investors and brings the total the company has raised to date to almost £4.5 million.